Clover Health Investments, Corp.

DB:7QD Stock Report

Market Cap: €1.6b

Clover Health Investments Management

Management criteria checks 3/4

Clover Health Investments' CEO is Andrew Toy, appointed in Jan 2023, has a tenure of 1.92 years. total yearly compensation is $10.15M, comprised of 6.9% salary and 93.1% bonuses, including company stock and options. directly owns 0.61% of the company’s shares, worth €9.50M. The average tenure of the management team and the board of directors is 2.4 years and 3.8 years respectively.

Key information

Andrew Toy

Chief executive officer

US$10.2m

Total compensation

CEO salary percentage6.9%
CEO tenure1.9yrs
CEO ownership0.6%
Management average tenure2.4yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Andrew Toy's remuneration changed compared to Clover Health Investments's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$96m

Jun 30 2024n/an/a

-US$121m

Mar 31 2024n/an/a

-US$157m

Dec 31 2023US$10mUS$700k

-US$213m

Sep 30 2023n/an/a

-US$226m

Jun 30 2023n/an/a

-US$268m

Mar 31 2023n/an/a

-US$344m

Dec 31 2022US$10mUS$500k

-US$340m

Sep 30 2022n/an/a

-US$443m

Jun 30 2022n/an/a

-US$402m

Mar 31 2022n/an/a

-US$615m

Dec 31 2021US$142mUS$450k

-US$588m

Sep 30 2021n/an/a

-US$527m

Jun 30 2021n/an/a

-US$487m

Mar 31 2021n/an/a

-US$160m

Dec 31 2020US$9mUS$415k

-US$136m

Sep 30 2020n/an/a

-US$89m

Jun 30 2020n/an/a

-US$145m

Mar 31 2020n/an/a

-US$272m

Dec 31 2019US$424kUS$400k

-US$364m

Compensation vs Market: Andrew's total compensation ($USD10.15M) is above average for companies of similar size in the German market ($USD1.58M).

Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.

CEO

Andrew Toy (45 yo)

1.9yrs

Tenure

US$10,154,701

Compensation

Mr. Andrew Toy Co-founded Clover Health Investments, Corp. and serves as its Director since November 2018 and served as its President since March 2019. He serves as Chief Executive Officer at Clover Health...

Leadership Team

NamePositionTenureCompensationOwnership
Vivek Garipalli
Co-Founder & Executive Chairman10.4yrsno data18.01%
€ 280.0m
Andrew Toy
Co-Founder1.9yrsUS$10.15m0.61%
€ 9.5m
Karen Soares
General Counsel1.2yrsUS$1.47m0.28%
€ 4.3m
Brady Priest
Chief Executive Officer of Home Care2.4yrsUS$1.35m0.16%
€ 2.5m
Jamie Reynoso
Chief Executive Officer of Medicare Advantage1.9yrsUS$2.49m0.26%
€ 4.0m
Peter Kuipers
Chief Financial Officerless than a yearno datano data
Conrad Wai
Chief Technology Officer2.8yrsno data0.67%
€ 10.5m
Derrick Nueman
Head of Investor Relations & Corporate strategyno datano datano data
Wendy Richey
Chief Compliance Officerno datano datano data
Rachel Fish
Chief People Officerno datano datano data
Kumar Dharmarajan
Chief Medical Officer of Clover Assistant3.1yrsno datano data
Mark Spektor
Chief Medical Officer3.9yrsno datano data

2.4yrs

Average Tenure

46yo

Average Age

Experienced Management: 7QD's management team is considered experienced (2.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Vivek Garipalli
Co-Founder & Executive Chairman10.4yrsno data18.01%
€ 280.0m
Andrew Toy
Co-Founder6.1yrsUS$10.15m0.61%
€ 9.5m
Lee Shapiro
Independent Director3.9yrsUS$280.93k0.066%
€ 1.0m
Thomas Tran
Directorless than a yearno datano data
Chelsea Clinton
Independent Director7.8yrsUS$246.55k0.067%
€ 1.0m
Phineas Barnes
Board Observerno datano datano data
William Robinson
Independent Director3.8yrsUS$268.43k0.050%
€ 780.4k
Carladenise Edwards
Independent Director2.4yrsUS$250.30k0.041%
€ 639.5k
Anna Loengard
Independent Director2.1yrsUS$247.80k0.077%
€ 1.2m
Demetrios Kouzoukas
Lead Independent Director3.7yrsUS$320.16k0.044%
€ 690.9k

3.8yrs

Average Tenure

50.5yo

Average Age

Experienced Board: 7QD's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:28
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Clover Health Investments, Corp. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin FischbeckBofA Global Research
Richard CloseCanaccord Genuity
Jason CassorlaCitigroup Inc